세계의 전신 아스페르길루스증 및 전신 칸디다증 시장(2024년판) : 유형별, 치료 접근법별, 최종 사용자별, 지역별, 국가별 분석, 시장 인사이트 및 예측(2020-2030년)

Executive Summary

Azoth Analytics has released a research report titled "Global Systemic Aspergillosis and Systemic Candidiasis Market (2024 Edition)" which provides a complete analysis of the Global Systemic Aspergillosis and Systemic Candidiasis industry in terms of market segmentation By Type (Candidiasis, Aspergillosis), By Treatment Approach (Antifungal Medications, Combination Therapy, and Surgical Intervention) By End Users (Hospitals, Clinics, Other End-users) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The report analyses the Global Systemic Aspergillosis and Systemic Candidiasis Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). The Global Systemic Aspergillosis and Systemic Candidiasis market showcased growth at a CAGR of 3.62% during 2020-2023.

The market was valued at USD 7.18 Billion in 2023 which is expected to reach USD 9.62 Billion in 2030. Growing disposable income levels, particularly among affluent consumers, have fuelled demand for premium anti-aging Surgical Intervention and skincare products.

Aspergillosis and candidiasis are among the most common fungal infections worldwide, affecting individuals with compromised immune systems, such as transplant recipients, cancer patients

undergoing chemotherapy, and those with HIV/AIDS. These infections can manifest as severe pulmonary, bloodstream, or invasive infections, leading to substantial morbidity and mortality if not promptly diagnosed and treated.

Antifungal drugs continue to serve as the foundation for treating systemic aspergillosis and systemic candidiasis, with azoles, echinocandins, and polyenes representing the primary

treatment options. Combinations of these medications may be utilized in cases where standard therapy proves ineffective or to combat instances of emerging drug resistance. In certain

scenarios, such as invasive pulmonary aspergillosis or fungal endocarditis, surgical procedures may be warranted as adjunctive therapy.

The Global Systemic Aspergillosis and Systemic Candidiasis Market experiences momentum due to rising occurrences of fungal infections, improved diagnostic methods, heightened awareness among healthcare practitioners and individuals, and the expanding array of antifungal treatments. Furthermore, factors such as population aging, immunosuppressive treatments, and hospital- acquired transmissions bolster the market's expansion.

The market is characterized by intense competition among key players, including pharmaceutical companies, and healthcare organizations. These companies are continuously innovating and launching new products and solutions to meet the evolving needs of healthcare providers, laboratories, and patients.

Scope of the Report:

• The report analyses the Systemic Aspergillosis and Systemic Candidiasis Market by Value (USD Billion).
• The report analyses the Systemic Aspergillosis and Systemic Candidiasis Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada,

Germany, United Kingdom, France, Italy, Spain, China, Japan, India).

• The report presents the analysis of Systemic Aspergillosis and Systemic Candidiasis Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
• The report analyses the Systemic Aspergillosis and Systemic Candidiasis Market By Type (Candidiasis, Aspergillosis)
• The report analyses the Systemic Aspergillosis and Systemic Candidiasis Market By Treatment Approach (Antifungal Medications, Combination Therapy, and Surgical Intervention).
• The report analyses the Systemic Aspergillosis and Systemic Candidiasis Market By End Users (Hospitals, Clinics, and Other End Users).
• The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Type, By Treatment Approach and By End User.
• Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Sanofi, Cipla, Pfizer, GSK PLC, Novartis AG, Bayer AG, Merck & Co., Inc., F. Hoffmann-La Roche AG, Abbott Laboratories and Gilead Sciences, Inc.

Table of Contents

Table of Content

1. Market Background

• 1.1 Scope and Product Outlook
• 1.2 Executive Summary
• 1.3 Research Methodology

2. Analyst Recommendations

• 2.1 Personalized Medicine
• 2.2 Penetrating Developing Markets

3. Global Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

• 3.1 Impact Analysis of Macro Economic Factors on Global Systemic Aspergillosis and Systemic Candidiasis Market
• 3.2 Annual incidence of commoner life-threatening fungal infections
• 3.3 Antifungal Therapies for Systemic Aspergillosis And Systemic Candidiasis in Pipeline
• 3.4 Global Systemic Aspergillosis and Systemic Candidiasis Market: Dashboard
• 3.5 Global Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
• 3.6 Global Systemic Aspergillosis and Systemic Candidiasis Market: Market Value Assessment
• 3.7 Assessment Degree of Impact of COVID-19 on Global Systemic Aspergillosis and Systemic Candidiasis Market
• 3.8 Global Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Type
  • 3.8.1 Global Systemic Aspergillosis and Systemic Candidiasis Market, By Type Overview
  • 3.8.2 Global Systemic Aspergillosis and Systemic Candidiasis Market Attractiveness Index, By Type
  • 3.8.3 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.8.4 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billion & CAGR)
• 3.9 Global Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Treatment Approach
  • 3.9.1 Global Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach Overview
  • 3.9.2 Global Systemic Aspergillosis and Systemic Candidiasis Market Attractiveness Index, By Treatment Approach
  • 3.9.3 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.9.4 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.9.5 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billion & CAGR)
• 3.10 Global Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By End-users
  • 3.10.1 Global Systemic Aspergillosis and Systemic Candidiasis Market, By End-users Overview
  • 3.10.2 Global Systemic Aspergillosis and Systemic Candidiasis Market Attractiveness Index, By End-users
  • 3.10.3 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.10.4 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.10.5 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)

4. Global Systemic Aspergillosis and Systemic Candidiasis Market, Region Analysis

• 4.1 Regional Coverage of the Study
• 4.2 Regional Snapshot

5. Americas Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

• 5.1 Americas Systemic Aspergillosis and Systemic Candidiasis Market: Snapshot
• 5.2 Americas Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
• 5.3 Americas Systemic Aspergillosis and Systemic Candidiasis Market: Key Factors
• 5.4 Americas Systemic Aspergillosis and Systemic Candidiasis Market: Segment Analysis
• 5.5 Americas Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Type
  • 5.5.1 Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Type Overview
  • 5.5.2 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.5.3 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billion & CAGR)
• 5.6 Americas Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: Treatment Approach
  • 5.6.1 Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach Overview
  • 5.6.2 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.6.3 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.6.4 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billion & CAGR)
• 5.7 Americas Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By End-users
  • 5.7.1 Americas Systemic Aspergillosis and Systemic Candidiasis Market, By End-users Overview
  • 5.7.2 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.7.3 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.7.4 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
• 5.8 Americas Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Country
  • 5.8.1 Americas Systemic Aspergillosis and Systemic Candidiasis Market, by Country Overview
  • 5.8.2 United States Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 5.8.2.1 United States Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 5.8.2.2 United States Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 5.8.2.3 United States Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
  • 5.8.3 Canada Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 5.8.3.1 Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 5.8.3.2 Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 5.8.3.3 Canada Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
  • 5.8.4 Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 5.8.4.1 Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 5.8.4.2 Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 5.8.4.3 Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By End-users

6. Europe Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

• 6.1 Europe Systemic Aspergillosis and Systemic Candidiasis Market: Snapshot
• 6.2 Europe Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
• 6.3 Europe Systemic Aspergillosis and Systemic Candidiasis Market: Key Factors
• 6.4 Europe Systemic Aspergillosis and Systemic Candidiasis Market: Segment Analysis
• 6.5 Europe Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Type
  • 6.5.1 Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Type Overview
  • 6.5.2 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.5.3 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billion & CAGR)
• 6.6 Europe Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Treatment Approach
  • 6.6.1 Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach Overview
  • 6.6.2 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.6.3 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.6.3 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billion & CAGR)
• 6.7 Europe Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By End-users
  • 6.7.1 Europe Systemic Aspergillosis and Systemic Candidiasis Market, By End-users Overview
  • 6.7.2 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.7.3 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.7.4 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
• 6.8 Europe Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Country
  • 6.8.1 Europe Systemic Aspergillosis and Systemic Candidiasis Market, by Country Overview
  • 6.8.2 Germany Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 6.8.2.1 Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 6.8.2.2 Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 6.8.2.3 Germany Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
  • 6.8.3 United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 6.8.3.1 United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 6.8.3.2 United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 6.8.3.3 United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
  • 6.8.4 France Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 6.8.4.1 France Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 6.8.4.2 France Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 6.8.4.3 France Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
  • 6.8.5 Italy Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 6.8.5.1 Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 6.8.5.2 Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 6.8.5.3 Italy Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
  • 6.8.6 Spain Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 6.8.6.1 Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 6.8.6.2 Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 6.8.6.3 Spain Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
  • 6.8.7 Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 6.8.7.1 Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 6.8.7.2 Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 6.8.7.3 Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By End-users

7. Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

• 7.1 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Snapshot
• 7.2 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
• 7.3 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Key Factors
• 7.4 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Segment Analysis
• 7.5 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Type
  • 7.5.1 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Type Overview
  • 7.5.2 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.5.3 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billion & CAGR)
• 7.6 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Treatment Approach
  • 7.6.1 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach Overview
  • 7.6.2 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.6.3 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.6.3 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billion & CAGR)
• 7.7 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By End-users
  • 7.7.1 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By End-users Overview
  • 7.7.2 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.7.3 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.7.4 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
• 7.8 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Country
  • 7.8.1 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, by Country Overview
  • 7.8.2 China Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 7.8.2.1 China Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 7.8.2.2 China Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 7.8.2.3 China Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
  • 7.8.3 Japan Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 7.8.3.1 Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 7.8.3.2 Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 7.8.3.3 Japan Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
  • 7.8.4 India Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 7.8.4.1 India Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 7.8.4.2 India Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 7.8.4.3 India Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
  • 7.8.5 Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 7.8.5.1 Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 7.8.5.2 Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 7.8.5.3 Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By End-users

8. Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

• 8.1 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market: Snapshot
• 8.2 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
• 8.3 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market: Key Factors
• 8.4 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market: Segment Analysis
• 8.5 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Type
  • 8.5.1 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Type Overview
  • 8.5.2 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.5.3 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billion & CAGR)
• 8.6 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Treatment Approach
  • 8.6.1 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach Overview
  • 8.6.2 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.6.3 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.6.3 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billion & CAGR)
• 8.7 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By End-users
  • 8.7.1 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By End-users Overview
  • 8.7.2 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.7.3 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.7.4 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)

9. Market Dynamics

• 9.1 Impact assessment of Market Dynamics on Systemic Aspergillosis and Systemic Candidiasis Market
• 9.2 Drivers
• 9.3 Restraints
• 9.4 Trends

10. Industry Ecosystem Analysis

• 10.1 Porter Analysis

11. Competitive Positioning

• 11.1 Companies' Product Positioning
• 11.2 Market Position Matrix
• 11.3 Market Share Analysis of Systemic Aspergillosis and Systemic Candidiasis Market
• 11.4 Company Profiles
  • 11.4.1 Sanofi
  • 11.4.2 Cipla
  • 11.4.3 Pfizer
  • 11.4.4 GSK PLC
  • 11.4.5 Novartis AG
  • 11.4.6 Bayer AG
  • 11.4.7 Merck & Co., Inc.
  • 11.4.8 F. Hoffmann-La Roche AG
  • 11.4.9 Abbott Laboratories
  • 11.4.10 Gilead Sciences, Inc.

12. About Us & Disclaimer